SBRA Quote, Financials, Valuation and Earnings

LXP Industrial Trust has a net margin of 25.61% compared to Sabra Health Care REIT's net margin of 32.75%. Sabra Health Care REIT's return on equity of 4.59% beat LXP Industrial Trust's return on equity of 2.04%.

Sabra Health Care REIT has a consensus price target of $19.50, signalling upside risk potential of 7.32%. On the other hand LXP Industrial Trust has an analysts' consensus of $10.60 which suggests that it could grow by 37.31%. Given that LXP Industrial Trust has higher upside potential than Sabra Health Care REIT, analysts believe LXP Industrial Trust is more attractive than Sabra Health Care REIT.

Sabra Health Care REIT has a beta of 0.936, which suggesting that the stock is 6.362% less volatile than S&P 500. In comparison LXP Industrial Trust has a beta of 0.951, suggesting its less volatile than the S&P 500 by 4.855%.

Sabra Health Care REIT has a quarterly dividend of $0.30 per share corresponding to a yield of 6.6%. LXP Industrial Trust offers a yield of 6.87% to investors and pays a quarterly dividend of $0.14 per share. Sabra Health Care REIT pays 221.09% of its earnings as a dividend. LXP Industrial Trust pays out 355.14% of its earnings as a dividend. Neither of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

Sabra Health Care REIT quarterly revenues are $182.3M, which are larger than LXP Industrial Trust quarterly revenues of $100.9M. Sabra Health Care REIT's net income of $46.7M is higher than LXP Industrial Trust's net income of $33M. Notably, Sabra Health Care REIT's price-to-earnings ratio is 34.28x while LXP Industrial Trust's PE ratio is 59.38x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Sabra Health Care REIT is 6.10x versus 6.28x for LXP Industrial Trust. Usually stocks with elevated PS ratios are considered overvalued.

Office Properties Income Trust has a net margin of 25.61% compared to Sabra Health Care REIT's net margin of -125.75%. Sabra Health Care REIT's return on equity of 4.59% beat Office Properties Income Trust's return on equity of -10.86%.

Sabra Health Care REIT has a consensus price target of $19.50, signalling upside risk potential of 7.32%. On the other hand Office Properties Income Trust has an analysts' consensus of $0.75 which suggests that it could grow by 130.49%. Given that Office Properties Income Trust has higher upside potential than Sabra Health Care REIT, analysts believe Office Properties Income Trust is more attractive than Sabra Health Care REIT.

Sabra Health Care REIT has a beta of 0.936, which suggesting that the stock is 6.362% less volatile than S&P 500. In comparison Office Properties Income Trust has a beta of 1.583, suggesting its more volatile than the S&P 500 by 58.284%.

Sabra Health Care REIT has a quarterly dividend of $0.30 per share corresponding to a yield of 6.6%. Office Properties Income Trust offers a yield of 12.29% to investors and pays a quarterly dividend of $0.01 per share. Sabra Health Care REIT pays 221.09% of its earnings as a dividend. Office Properties Income Trust pays out -1.49% of its earnings as a dividend.

Sabra Health Care REIT quarterly revenues are $182.3M, which are larger than Office Properties Income Trust quarterly revenues of $118.2M. Sabra Health Care REIT's net income of $46.7M is higher than Office Properties Income Trust's net income of -$148.7M. Notably, Sabra Health Care REIT's price-to-earnings ratio is 34.28x while Office Properties Income Trust's PE ratio is 8.15x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Sabra Health Care REIT is 6.10x versus 0.03x for Office Properties Income Trust. Usually stocks with elevated PS ratios are considered overvalued.

Pebblebrook Hotel Trust has a net margin of 25.61% compared to Sabra Health Care REIT's net margin of -14.95%. Sabra Health Care REIT's return on equity of 4.59% beat Pebblebrook Hotel Trust's return on equity of -0.15%.

Sabra Health Care REIT has a consensus price target of $19.50, signalling upside risk potential of 7.32%. On the other hand Pebblebrook Hotel Trust has an analysts' consensus of $12.87 which suggests that it could grow by 54.07%. Given that Pebblebrook Hotel Trust has higher upside potential than Sabra Health Care REIT, analysts believe Pebblebrook Hotel Trust is more attractive than Sabra Health Care REIT.

Sabra Health Care REIT has a beta of 0.936, which suggesting that the stock is 6.362% less volatile than S&P 500. In comparison Pebblebrook Hotel Trust has a beta of 1.688, suggesting its more volatile than the S&P 500 by 68.813%.

Sabra Health Care REIT has a quarterly dividend of $0.30 per share corresponding to a yield of 6.6%. Pebblebrook Hotel Trust offers a yield of 0.47% to investors and pays a quarterly dividend of $0.01 per share. Sabra Health Care REIT pays 221.09% of its earnings as a dividend. Pebblebrook Hotel Trust pays out -1226.97% of its earnings as a dividend.

Sabra Health Care REIT quarterly revenues are $182.3M, which are smaller than Pebblebrook Hotel Trust quarterly revenues of $337.6M. Sabra Health Care REIT's net income of $46.7M is higher than Pebblebrook Hotel Trust's net income of -$50.5M. Notably, Sabra Health Care REIT's price-to-earnings ratio is 34.28x while Pebblebrook Hotel Trust's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Sabra Health Care REIT is 6.10x versus 0.79x for Pebblebrook Hotel Trust. Usually stocks with elevated PS ratios are considered overvalued.

Ventas has a net margin of 25.61% compared to Sabra Health Care REIT's net margin of 4.42%. Sabra Health Care REIT's return on equity of 4.59% beat Ventas's return on equity of 0.81%.

Sabra Health Care REIT has a consensus price target of $19.50, signalling upside risk potential of 7.32%. On the other hand Ventas has an analysts' consensus of $75.63 which suggests that it could grow by 11.83%. Given that Ventas has higher upside potential than Sabra Health Care REIT, analysts believe Ventas is more attractive than Sabra Health Care REIT.

Sabra Health Care REIT has a beta of 0.936, which suggesting that the stock is 6.362% less volatile than S&P 500. In comparison Ventas has a beta of 1.017, suggesting its more volatile than the S&P 500 by 1.691%.

Sabra Health Care REIT has a quarterly dividend of $0.30 per share corresponding to a yield of 6.6%. Ventas offers a yield of 2.71% to investors and pays a quarterly dividend of $0.48 per share. Sabra Health Care REIT pays 221.09% of its earnings as a dividend. Ventas pays out 912.26% of its earnings as a dividend. Neither of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

Sabra Health Care REIT quarterly revenues are $182.3M, which are smaller than Ventas quarterly revenues of $1.3B. Sabra Health Care REIT's net income of $46.7M is lower than Ventas's net income of $56.8M. Notably, Sabra Health Care REIT's price-to-earnings ratio is 34.28x while Ventas's PE ratio is 355.95x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Sabra Health Care REIT is 6.10x versus 5.72x for Ventas. Usually stocks with elevated PS ratios are considered overvalued.